Medtronic's stock hasn't been for faint-of-heart
Medtronic's stock lately hasn't been for the faint-of-heart, says USA Today investment columnist Matt Krantz.
But the company's "been a strong performer over the years and deserves a closer look," he continues.
One indicator: the company is in good financial shape, based on where it scores on USA Today's Stock Meter.
The company's stock is also inexpensive relative to the amount of cash it's expected to generate.
Most Commented